News
Pasteur Network and WFPHA Join Forces to Advance Global Public Health
The Pasteur Network and the World Federation of Public Health Associations (WFPHA) have signed a MoU to establish a collaborative framework to enhance global public health. This collaboration aims to leverage the strengths of both organizations to address critical public health challenges through research, policy advocacy, capacity building, and the promotion of health equity.
Collaborative Efforts
The collaboration will focus on several key areas:
- Epidemic Intelligence & Preparedness: Enhancing epidemic intelligence and preparedness through joint surveillance and research initiatives, particularly on climate-sensitive diseases.
- Research, Development, & Innovation: Advancing scientific understanding and technological innovations in public health and biomedicine.
- Policy Development and Advocacy: Developing and promoting global public health policies to positively influence health outcomes.
- Capacity Building: Strengthening the capabilities of public health professionals and organizations through training programs, workshops, and knowledge exchange initiatives.
- Promotion of Health Equity: Implementing strategies that promote equitable health outcomes across different populations.
Duration and Future Prospects
The MoU is effective for three years, with the possibility of extension by mutual agreement. This partnership marks a significant step towards enhancing global public health. By combining their expertise and resources, the Pasteur Network and WFPHA aim to make substantial contributions to public health research, policy, and practice, ultimately improving health outcomes worldwide.
Latest posts
20 May 2026
Global health leaders call for coordinated action to strengthen equitable and sustainable clinical trials systems at World Health Assembly side event
News
11 May 2026
Pasteur Network and Climate Action Accelerator Partner to Strengthen Climate Action and Decarbonisation in Global Health and Research
News
23 April 2026
Pasteur Network and IVI convene high-level dialogue on strengthening clinical trial systems at WHA79
News